Radiopharmaceutical Imaging and Dosimetry
Curated by SignalQuantitative imaging and dosimetry software for Radiopharmaceutical therapy (RPT)
Overview
Radiopharmaceutical Imaging and Dosimetry is developing quantitative imaging and dosimetry software for Radiopharmaceutical therapy (RPT). Clinical trials of RPT agents require and optimal therapeutic regimens are likely to be based on quantitative imaging and dosimetry to predict tumor response and normal organ toxicity. The founders of the company claim to have developed a model to predict response to cancer therapy. The company received a SBIR grant in 2016 to develop and demonstrate the feasibility of software tool chain to enable a dosimetry service product for RPT cancer developers.
Key facts
- Founded
- 2016
- Headquarters
- Baltimore, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 6 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view